Spinal Visceral Motor Neurons are preganglionic autonomic neurons located in the intermediolateral cell column of the spinal cord that control involuntary functions of visceral organs. These neurons form the efferent arm of the autonomic nervous system, regulating cardiovascular, respiratory, gastrointestinal, and urogenital functions[1].
In neurodegenerative diseases, spinal visceral motor neurons are particularly vulnerable to pathology that disrupts autonomic function, leading to common non-motor symptoms such as orthostatic hypotension, urinary dysfunction, and sleep disturbances[2].
| Property | Value |
|---|---|
| Category | Spinal Cord Autonomic |
| Location | Intermediolateral cell column (T1-L2 parasympathetic, S2-S4 parasympathetic) |
| Cell Types | Preganglionic autonomic neurons |
| Primary Neurotransmitter | Acetylcholine |
| Key Markers | ChAT, Phox2b, Pitx2 |
Spinal visceral motor neurons are organized in two main populations:
Thoracolumbar (Sympathetic):
Sacral (Parasympathetic):
These neurons are characterized by:
Spinal visceral motor neurons regulate autonomic homeostasis through:
Cardiovascular Control:
Respiratory Control:
Gastrointestinal Control:
Urogenital Function:
Spinal visceral motor neurons receive descending input from:
MSA is characterized by severe degeneration of spinal visceral motor neurons:
While primarily a dopaminergic disorder, PD affects autonomic pathways:
Damage to spinal visceral motor neurons causes:
ALS can affect autonomic neurons:
Assessment of spinal visceral motor neuron function includes:
Pharmacological Approaches:
Neuromodulation:
Rehabilitation:
Current research focuses on:
The study of Spinal Visceral Motor Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Morgan CW. Spinal autonomic neurons. Neuroscience. 1999;94(4):1247-1264. 1999. ↩︎
[Kalia LV, Lang AE. Parkinson's disease. Lancet. 2015;386(9996):896-912](https://doi.org/10.1016/S0140-6736(14). 2015. ↩︎
Nadelhaft I, Booth AM. The location and morphology of preganglionic neurons and efferent preganglionic axons. J Comp Neurol. 1984;229(1):121-128. 1984. ↩︎
Dampney RA. Functional organization of central pathways regulating the cardiovascular system. Physiol Rev. 1994;74(2):323-364. 1994. ↩︎
Fowler CJ, Griffiths D, de Groat WC. The neural control of micturition. Nat Rev Neurosci. 2008;9(6):453-466. 2008. ↩︎
[Wenning GK, Colosimo C, Geser F, Poewe W. Multiple system atrophy. Lancet Neurol. 2004;3(2):93-103](https://doi.org/10.1016/S1474-4422(03). 2004. ↩︎
Jellinger KA. Neuropathology of multiple system atrophy: new thoughts about pathogenesis. Mov Disord. 2014;29(4):432-446. 2014. ↩︎
[Krassioukov A, Claydon VE. The clinical problems in cardiovascular control following spinal cord injury: an overview. Prog Brain Res. 2006;152:223-229](https://doi.org/10.1016/S0079-6123(05). 2006. ↩︎
Burgess RW, Balice-Gordon RJ. ALS and autonomic dysfunction. J Neurol. 2015;262(5):1233-1244. 2015. ↩︎
Benarroch EE. Autonomic nervous system and sleep. Handb Clin Neurol. 2011;98:241-253. 2011. ↩︎